Valuing a Pharmaceutical Asset: a new, data-rich tool for estimating a drug's true value (US)
October 11, 2018

With approval rates declining and clinical trial costs soaring, it’s difficult to accurately value a pharmaceutical product in development. Now there’s a new technology platform that aims to drive more accurate, data driven valuations. Pipeline Architect builds on IQVIA’s massive data sets on clinical trial timing, costs, revenues and success rates, to value an asset quickly and accurately. Whether you need to value a new business development or licensing deal, or determine the value of your own products in development, Pipeline Architect delivers best-in-class asset valuations.

Contact Us
Contact Us
Contact Us

Email Us

Get in touch today to discover the right solutions for you.

Call Us

We are pleased to speak with you during our standard business hours.

U.S. Toll-Free only
+1 866 267 4479

For international call please find a number in our toll-free list.

Media Inquiries

Please use this form to reach out to our media team with inquiries. Thank you.